Erythropoietin Levels in Anemic Chronic Heart Failure Patients

Erythropoietin Levels in Anemic Chronic Heart Failure Patients


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,396

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Heart Failure is a progressive disease in which initial cardiac damage leads to further deterioration of cardiac function and, finally, damage the other organs. Heart disease and kidney disease are intertwined. Red blood cells are produced in the bone marrow under the influence of a hormone called Erythropoietin (EPO). EPO is glycosylated protein (molecular weight 30,000 - 34,000 Daltons). When kidney disease develops, the production of EPO by kidneys goes down, resulting in anemia. Anemia can propagate and worsen heart failure. The principal functions of EPO are to stimulate proliferation and maturation of bone marrow erythroid precursors, to affect the expansion of progenitor cells by repressing apoptosis, to act as a mitogen for increasing EPO production, to decreases maturation time of erythrocytes in the bone marrow and effective alternative to red-cell transfusion. Recombinant EPO has been used in treatment of Anemia of chronic diseases e.g. heart, liver, HIV and Anemia associated with cancer radiation therapy and chemotherapy. The use of Erythropoietin will result in increased hemoglobin related to improved outcomes in patients with CHF-associated anemia.

Product Specifications
SKU :COC99355
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-08-18
0 Review(s)